Study also discovered a rapid change in practise for breast cancer treatments
News
Keytruda scores new EU approval in colorectal cancer
First checkpoint inhibitor to be approved in the EU to treat MSI-H or dMMR colorectal cancer
New NHS Medtech Funding Mandate welcomed by BIVDA
System will allow ‘in vitro diagnostics devices a faster and easier route to market’
NICE recommends Revlimid for newly diagnosed multiple myeloma patients
Cost-effectiveness agency initially turned down the drug in this setting
Wren Therapeutics raises £12.4m in latest financing round
Biopharma company has raised approximately £33m to date
Roche’s faricimab hits primary endpoint in wet AMD studies
Bispecific antibody met non-inferiority measure compared to Regeneron’s Eylea
AbbVie’s Rinvoq bags two new EU approvals
Oral JAK inhibitor approved for psoriatic arthritis and ankylosing spondylitis
Moderna says its COVID-19 vaccine works effectively against variants
Lab tests evaluated vaccine’s efficacy against UK and South African variants
PharmaTimes confirms INTCR 2021 virtual finals days
The 2021 International Clinical Researcher of the Year competition will continue the successes of last year and be conducted virtually.
Calquence tops Imbruvica in chronic lymphocytic leukaemia study
BTK inhibitor demonstrated non-inferior progression-free survival compared to Imbruvica
NHS COVID-19 vaccination drive bolstered by new centres
Over 30 new vaccination centres open across England
Psychiatry Consortium funds project investigating new schizophrenia treatments
Project will see the University of Oxford partner with the Earlham Institute, Biogen and Boehringer Ingelheim
EU approval for Bavencio in bladder cancer
Approved for the maintenance treatment of advanced urothelial carcinoma
Servier and MiNA Therapeutics ink neurology pact
Companies will develop saRNA therapies to treat neurological diseases
US green light for long-acting HIV regimen Cabenuva
Cabenuva consists of ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine
